Pleural MAC30 as a prognostic marker in NSCLC with malignant pleural effusion.

about

Pleural MAC30 as a prognostic marker in NSCLC with malignant pleural effusion.

Item

http://www.wikidata.org/entity/Q47653286

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Pleural MAC30 as a prognostic marker in NSCLC with malignant pleural effusion.

@en

Pleural MAC30 as a prognostic marker in NSCLC with malignant pleural effusion.

@nl

type

Item

label

Pleural MAC30 as a prognostic marker in NSCLC with malignant pleural effusion.

@en

Pleural MAC30 as a prognostic marker in NSCLC with malignant pleural effusion.

@nl

prefLabel

Pleural MAC30 as a prognostic marker in NSCLC with malignant pleural effusion.

@en

Pleural MAC30 as a prognostic marker in NSCLC with malignant pleural effusion.

@nl

P1476

Pleural MAC30 as a prognostic marker in NSCLC with malignant pleural effusion.

@en

P2093

Hui Ding

http://www.w3.org/2001/XMLSchema#string

Junjie Lu

http://www.w3.org/2001/XMLSchema#string

Yi Shan

http://www.w3.org/2001/XMLSchema#string

Yongfei Tan

http://www.w3.org/2001/XMLSchema#string

Zhijun Ge

http://www.w3.org/2001/XMLSchema#string

P2860

Identification and characterization of genes differentially expressed in meningiomas

Revisiting stage IIIB and IV non-small cell lung cancer: analysis of the surveillance, epidemiology, and end results data.

Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer.

Clinical diagnostic utility of CA 15-3 for the diagnosis of malignant pleural effusion: A meta-analysis.

Diagnostic value of tumor antigens in malignant pleural effusion: a meta-analysis

Diagnostic utility of pleural fluid carcinoembryonic antigen and CYFRA 21-1 in patients with pleural effusion: a systematic review and meta-analysis.

Diagnostic value of carcinoembryonic antigen in malignant pleural effusion: a meta-analysis.

Reactive oxygen species modulator 1 (Romo1) as a novel diagnostic marker for lung cancer-related malignant effusion.

Diagnostic molecular biomarkers for malignant pleural effusions.

Clinical features and survival of lung cancer patients with pleural effusions.

P304

112809-112815

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.22631

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29348867

http://www.w3.org/2001/XMLSchema#string

P932

5762552

http://www.w3.org/2001/XMLSchema#string